Adamis Pharms Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADAMIS PHARMS CORP, and when can generic versions of ADAMIS PHARMS CORP drugs launch?
ADAMIS PHARMS CORP has one approved drug.
There is one US patent protecting ADAMIS PHARMS CORP drugs.
There are thirty patent family members on ADAMIS PHARMS CORP drugs in seventeen countries.
Summary for Adamis Pharms Corp
| International Patents: | 30 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Adamis Pharms Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adamis Pharms Corp | SYMJEPI | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 207534-002 | Sep 27, 2018 | DISCN | Yes | No | 11,141,540 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Adamis Pharms Corp | SYMJEPI | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 207534-001 | Jun 15, 2017 | RX | Yes | Yes | 11,141,540 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Adamis Pharms Corp Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 114028655 | ⤷ Subscribe |
| Hong Kong | 1254290 | ⤷ Subscribe |
| China | 107921219 | ⤷ Subscribe |
| Japan | 2018531643 | ⤷ Subscribe |
| Mexico | 2018002334 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
